This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,112.45, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of October 29, 2024. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. In addition to this delivery order, AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Generated 2/2/25, 12:06 AM